Total Payments
$1,009
2024 Payments
$75.56
Companies
20
Transactions
61
Medicare Patients
281
Medicare Billing
$9,012
Payment Breakdown by Category
Food & Beverage$935.03 (92.7%)
Education$74.07 (7.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $935.03 | 58 | 92.7% |
| Education | $74.07 | 3 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $139.98 | 10 | $0 (2024) |
| ABBVIE INC. | $131.00 | 6 | $0 (2024) |
| Lilly USA, LLC | $98.51 | 6 | $0 (2023) |
| Allergan, Inc. | $95.75 | 5 | $0 (2020) |
| Astellas Pharma US Inc | $85.25 | 4 | $0 (2017) |
| Novo Nordisk Inc | $73.06 | 5 | $0 (2023) |
| PFIZER INC. | $71.87 | 6 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $44.92 | 3 | $0 (2022) |
| Exact Sciences Corporation | $40.14 | 2 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $39.18 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.56 | 4 | ABBVIE INC. ($47.13) |
| 2023 | $338.41 | 18 | AbbVie Inc. ($83.87) |
| 2022 | $103.52 | 7 | Novo Nordisk Inc ($41.57) |
| 2021 | $119.41 | 9 | AstraZeneca Pharmaceuticals LP ($54.35) |
| 2020 | $66.33 | 4 | Allergan, Inc. ($53.53) |
| 2019 | $74.76 | 6 | PFIZER INC. ($49.95) |
| 2018 | $110.23 | 6 | AstraZeneca Pharmaceuticals LP ($45.09) |
| 2017 | $120.88 | 7 | Astellas Pharma US Inc ($85.25) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: VIROLOGY | ||||||
| 01/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: VIROLOGY | ||||||
| 10/03/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 08/16/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 08/10/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardio-renal | ||||||
| 07/25/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Neurology | ||||||
| 07/13/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 06/29/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.81 | General |
| Category: SLEEP MEDICINE | ||||||
| 06/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 05/24/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: VIROLOGY | ||||||
| 04/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Oncology | ||||||
| 02/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Oncology | ||||||
| 01/25/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 11/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Diabetes | ||||||
| 08/24/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 43 | 59 | $963.00 | $415.28 |
| 2022 | 2 | 61 | 87 | $1,435 | $672.52 |
| 2021 | 5 | 141 | 263 | $21,760 | $7,519 |
| 2020 | 1 | 36 | 42 | $714.00 | $405.73 |
Total Patients
281
Total Services
451
Medicare Billing
$9,012
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 39 | $663.00 | $371.28 | 56.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 20 | $300.00 | $44.00 | 14.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 42 | 65 | $1,105 | $623.74 | 56.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 22 | $330.00 | $48.78 | 14.8% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 36 | 100 | $10,000 | $3,391 | 33.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 30 | 50 | $7,500 | $2,657 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 15 | $2,670 | $803.16 | 30.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 40 | 60 | $1,020 | $582.60 | 57.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 24 | 38 | $570.00 | $85.50 | 15.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 36 | 42 | $714.00 | $405.73 | 56.8% |
About Dr. Jequita Snyder, D.O
Dr. Jequita Snyder, D.O is a Family Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255511309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jequita Snyder, D.O has received a total of $1,009 in payments from pharmaceutical and medical device companies, with $75.56 received in 2024. These payments were reported across 61 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($935.03).
As a Medicare-enrolled provider, Snyder has provided services to 281 Medicare beneficiaries, totaling 451 services with total Medicare billing of $9,012. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Miami, OK
- Active Since 11/06/2007
- Last Updated 07/09/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255511309
Products in Payments
- VRAYLAR (Drug) $92.25
- Myrbetriq (Drug) $85.25
- MAVYRET (Drug) $73.07
- JARDIANCE (Drug) $66.82
- FARXIGA (Drug) $54.86
- UBRELVY (Drug) $49.20
- SYMBICORT (Drug) $45.09
- Rybelsus (Drug) $42.53
- Cologuard Collection Kit (Device) $40.14
- JORNAY PM (Drug) $39.18
- TRELEGY ELLIPTA (Drug) $35.72
- Ozempic (Drug) $30.53
- XARELTO (Drug) $28.18
- XIFAXAN (Drug) $26.09
- CHANTIX (Drug) $25.70
- LYRICA (Drug) $24.25
- Prolia (Biological) $21.06
- WAKIX (Drug) $19.81
- UZEDY (Drug) $18.42
- TRULICITY (Drug) $17.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Miami
Keila Hoover, M.d, M.D
Family Medicine — Payments: $1.1M
Family Medicine $1.1M
Dr. Yamirka Duardo-Guerra, M.d, M.D
Family Medicine — Payments: $1.0M
Family Medicine $1.0M
Ramon Leon, Md, MD
Family Medicine — Payments: $179,798
Family Medicine $179,798
Mirel Sanchez, M.d, M.D
Family Medicine — Payments: $165,828
Family Medicine $165,828
Gilberto Seco, Md, MD
Family Medicine — Payments: $127,612
Family Medicine $127,612
Dr. Clifford Kinder, Md, MD
Family Medicine — Payments: $121,261
Family Medicine $121,261